Promoter entity acquires 14,00,000 shares on conversion of fully convertible warrants

Promoter group entity Essix Biosciences Limited has acquired 14,00,000 equity shares of Rs. 10/- each on conversion of fully convertible warrants.

Mon 12 Oct 2026

Shares acquired on warrant conversion

14,00,000 equity shares of Rs. 10/- each

Holding after conversion

3,42,82,521 shares (38.80%)

Warrants still to be converted

56,00,000

What happened

Essix Biosciences Limited, which belongs to the promoter and promoter group of Ind-Swift Laboratories Limited, has acquired 14,00,000 (Fourteen Lakh) equity shares of face value Rs. 10/- each. The shares were acquired on conversion of fully convertible warrants that had been allotted through a preferential issue by the target company. The date of allotment is October 08, 2026.

Holding before and after

• Before: the acquirer held 3,28,82,521 shares, or 37.81% of the total share/voting capital (35.00% on a diluted basis).
• Persons acting in concert (PACs) held 44,51,757 shares, or 5.12% (4.74% diluted).
• Warrants/convertible securities held by the acquirer before: 70,00,000, i.e. 7.45% on a diluted basis.
• Shares acquired in this transaction: 14,00,000, or 1.58% (1.49% diluted).
• After: the acquirer holds 3,42,82,521 shares, or 38.80% (36.48% diluted).
• PACs hold 44,51,757 shares, or 5.04% (4.74% diluted).
• Warrants still held by the acquirer after the allotment: 56,00,000, i.e. 5.96% on a diluted basis.

Promoter group total

Adding shares carrying voting rights, shares in the nature of encumbrance, voting rights otherwise than by shares, and convertible instruments, the total for the acquirer and PACs is 4,43,34,278, which is 43.84% of the total share/voting capital and 47.18% on a diluted basis.

Share capital

• Before the acquisition: equity share capital of Rs. 86.96 crore, comprising 8,69,61,558 equity shares of Rs. 10/- each.
• After the acquisition: Rs. 88,36,15,580/-, comprising 8,83,61,558 equity shares of Rs. 10/- each.
• Total diluted share/voting capital after the acquisition: Rs. 93.96 crore, comprising 9,39,61,558 equity shares of Rs. 10/- each.

Encumbrance

Shares in the nature of encumbrance held before and after the acquisition are shown as 0, with 0.00% against each.

How to read it

Conversion of warrants into shares increases the number of outstanding equity shares, so stakes are measured on a larger share base after the allotment. The acquirer's stake moves up from 37.81% to 38.80% of the total share/voting capital, while a further 56,00,000 warrants still held would add shares if and when converted.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.